Development of HIV non-vaccine biomedical prevention products: product attributes, positioning, and messaging, to drive adoption and use of new personal use products among young, urban and…
Ended Awarded Last action
- Contract number
- HHSN27200006
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $533,029
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 100% obligated
- $533,028.94 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $3,039 | |
| Funding Only Action | $31,891 | |
| Original award | $498,099 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL). The $533,028.94 contract is for the development of HIV non-vaccine biomedical prevention products, including assessing product attributes, positioning, and messaging to drive adoption and use of new personal use products among young, urban and peri-urban South African women. The contract is not set aside and is part of the larger "HIV Microbicides and Biomedical Prevention 2016-2021" IDIQ vehicle. ABL is a contract research and manufacturing organization specializing in biologics development, with extensive experience supporting NIH and HHS agencies through prime and subcontracts, including manufacturing, testing, and assay services for vaccine and therapeutic candidates.
Description
Development of HIV non-vaccine biomedical prevention products: product attributes, positioning, and messaging, to drive adoption and use of new personal use products among young, urban and peri-urban south african women
Quick answers
Who was awarded contract HHSN27200006?
HHSN27200006 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 26, 2017.
How much is contract HHSN27200006 worth?
The government has obligated $533,029 on HHSN27200006.
Is contract HHSN27200006 an order under another contract?
Yes. HHSN27200006 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract HHSN27200006 competed?
The extent of competition for HHSN27200006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award